cupure logo
cdcexpertsheartriskagencystudydoctorvaccinemillionssymptoms

FDA lifts pause on vaccine against the virus in China sparking global epidemic fears

FDA lifts pause on vaccine against the virus in China sparking global epidemic fears
The Ixchiq vaccine was approved for adults 18 and up at risk of exposure to the virus in 2023, when the CDC had recorded 152 travel-associated cases of the virus, the highest rate in four years.

Comments

Similar News

Health news